A recent study indicates that a compound produced in the body from vitamin A might hinder the immune system’s ability to combat cancer effectively. While vitamin A is vital for health, its byproduct seems to unintentionally suppress certain immune responses against cancer, as found in research published in Nature Immunology.
The study suggested that blocking this byproduct could help restore immune function and enhance the effectiveness of cancer immunotherapy. Researchers from the Princeton University Branch of the Ludwig Cancer Institute made this discovery while studying dendritic cells, which are essential for activating the body’s immune defenses.
As these cells matured in the lab, the scientists observed that they activated an enzyme that generates retinoic acid, a substance derived from vitamin A. This retinoic acid appears to diminish the dendritic cells’ ability to elicit a robust immune response. Consequently, the efficacy of dendritic cell vaccines—therapies intended to train the immune system to target cancer—was also reduced.
Furthermore, when retinoic acid levels were decreased, the dendritic cells regained strength, showing a greater capacity to activate T cells, which play a critical role in killing cancer cells.
In a related study published in iScience, the research team explored methods to create drugs that could inhibit this process. They utilized computer modeling and extensive drug screening to develop a small molecule that blocks the enzyme responsible for producing retinoic acid. This led to a promising inhibitor, which they used in their initial experiments.
Overall, lead researcher Yibin Kang emphasized that their findings reveal the significant impact of retinoic acid in dampening vital immune responses against cancer. They also managed to tackle a longstanding challenge in pharmacology by creating a safe and selective inhibitor of retinoic acid signaling, providing initial proof of concept for its potential use in cancer immunotherapy.
Research Limitations
It’s important to note that these findings stem from laboratory and animal models, and may not entirely reflect how retinoic acid functions in humans. The study specifically focused on a certain molecule derived from vitamin A, rather than addressing dietary vitamin A intake or overall vitamin A levels.
Notably, according to the National Institutes of Health, vitamin A is still considered an essential nutrient for normal immune functionality, growth, and vision. Extensive human studies have not found any evidence suggesting that vitamin A contributes to cancer development.
